const prostateCancer = {
    "page": {
        "type": "condition",
        "specialty": "urology",
        "slug": "/specialties/urology/conditions/prostate-cancer"
    },
    "metadata": {
        "title": "Prostate Cancer: PSA, MRI, Biopsy, Treatment Options & Focal Therapy | MyDocsy (Mumbai, Delhi NCR, Bangalore, Ahmedabad, Hyderabad, Chennai, Kolkata, Kochi)",
        "description": "Prostate cancer ranges from slow-growing disease needing monitoring to higher-risk disease needing treatment. A doctor-led guide to PSA, MRI (PI-RADS), biopsy (Gleason/Grade Group), staging, active surveillance, surgery/radiation, and where focal therapy and cryoablation may fit in selected cases."
    },
    "blocks": [
        {
            "type": "text",
            "title": "Prostate cancer: the right decision depends on your risk—not on fear",
            "content": "Hearing \"prostate cancer\" often triggers one immediate assumption: that everything must happen quickly. In reality, prostate cancer is not one single disease. It ranges from: very slow-growing cancers that can be monitored safely for years, to higher-risk cancers where timely treatment improves outcomes.\n\nA protective plan focuses on three things:\n1. Confirm the diagnosis properly (PSA, MRI, biopsy details).\n2. Understand the risk category (how aggressive is it; how likely is it to spread).\n3. Choose a treatment path that matches that risk and preserves quality of life.\n\nYou should never be rushed into treatment without a clear risk-based explanation. You also should not delay high-risk disease out of uncertainty."
        },
        {
            "type": "links",
            "title": "Quick navigation",
            "items": [
                {
                    "href": "#symptoms",
                    "label": "Symptoms and common misunderstandings"
                },
                {
                    "href": "#diagnosis",
                    "label": "How prostate cancer is diagnosed: PSA → MRI → biopsy"
                },
                {
                    "href": "#biopsy-report",
                    "label": "Understanding your biopsy report: Gleason/Grade Group"
                },
                {
                    "href": "#staging",
                    "label": "Staging in plain language"
                },
                {
                    "href": "#treatment",
                    "label": "Treatment pathways: active surveillance vs treatment"
                },
                {
                    "href": "#surgery-vs-radiation",
                    "label": "Surgery vs radiation: how the choice is made"
                },
                {
                    "href": "#focal-therapy",
                    "label": "Focal therapy and cryoablation: where they fit (selected cases)"
                },
                {
                    "href": "#follow-up",
                    "label": "Follow-up after treatment"
                },
                {
                    "href": "#next-page",
                    "label": "Which page should you go to next"
                },
                {
                    "href": "#faqs",
                    "label": "FAQs"
                }
            ]
        },
        {
            "type": "composite",
            "title": "Symptoms and common misunderstandings",
            "items": [
                {
                    "title": "\"Do urinary symptoms mean prostate cancer?\"",
                    "body": [
                        {
                            "type": "text",
                            "content": "Usually, no. Urinary symptoms (weak stream, nocturia, urgency) are more commonly due to BPH. Prostate cancer often causes no urinary symptoms in early stages.\n\nIf your main problem is urinary symptoms, you may be looking for:"
                        },
                        {
                            "type": "links",
                            "items": [
                                {
                                    "href": "/specialties/urology/conditions/bph",
                                    "label": "BPH"
                                },
                                {
                                    "href": "/specialties/urology/conditions/luts-incontinence",
                                    "label": "LUTS and Incontinence"
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "\"If PSA is high, is it definitely cancer?\"",
                    "body": [
                        {
                            "type": "text",
                            "content": "No. PSA can rise due to: BPH, inflammation/infection, recent instrumentation, ejaculation/exercise patterns in some contexts.\n\nPSA is a signal to evaluate—not a diagnosis."
                        }
                    ]
                }
            ]
        },
        {
            "type": "composite",
            "title": "How prostate cancer is diagnosed (the usual pathway)",
            "items": [
                {
                    "title": "Step 1: PSA in context",
                    "body": [
                        {
                            "type": "text",
                            "content": "A careful pathway avoids both over-treatment and delay.\n\nPSA is interpreted with: age, prostate size (often via ultrasound/MRI), PSA trend over time (velocity), clinical exam findings (when relevant)."
                        }
                    ]
                },
                {
                    "title": "Step 2: MRI prostate (mpMRI) in many cases",
                    "body": [
                        {
                            "type": "text",
                            "content": "MRI helps: identify suspicious lesions, guide targeted biopsy, provide additional risk information (PI-RADS scoring).\n\nMRI does not replace biopsy, but it improves decision-making."
                        }
                    ]
                },
                {
                    "title": "Step 3: Biopsy (targeted/systematic as appropriate)",
                    "body": [
                        {
                            "type": "text",
                            "content": "Biopsy confirms: whether cancer is present, how aggressive it appears under microscope, extent/volume of cancer in sampled cores."
                        }
                    ]
                }
            ]
        },
        {
            "type": "text",
            "title": "Understanding your biopsy report: Gleason and Grade Group (plain language)",
            "content": "Your biopsy report often includes: Gleason score (a pattern-based grading system), Grade Group (a simplified grouping used widely).\n\nWhat matters practically: lower grade groups are often candidates for surveillance in selected cases, higher grade groups usually require definitive treatment planning, \"volume\" (how much cancer in cores) also matters.\n\nA good consult will walk you through your report line by line. You should not have to guess."
        },
        {
            "type": "text",
            "title": "Staging in plain language",
            "content": "Staging helps determine whether disease is: localized to prostate, locally advanced (nearby extension), spread to nodes or bone/other sites.\n\nStaging may involve: MRI features, selected scans depending on risk category, blood markers in context.\n\nThe guiding principle is: staging intensity should match risk. Not everyone needs advanced scans."
        },
        {
            "type": "composite",
            "title": "Treatment pathways: surveillance vs treatment",
            "items": [
                {
                    "title": "Pathway A: Active surveillance (selected patients)",
                    "body": [
                        {
                            "type": "text",
                            "content": "This is where prostate cancer care is often misunderstood.\n\nActive surveillance is a structured medical strategy for cancers likely to grow slowly.\n\nIt typically includes: regular PSA monitoring, periodic MRI, repeat biopsies as indicated, clear triggers for switching to treatment.\n\nSurveillance is not denial. It is a risk-based approach that avoids unnecessary side effects when cancer is unlikely to harm you in the near-to-medium term."
                        }
                    ]
                },
                {
                    "title": "Pathway B: Definitive treatment (when risk warrants it)",
                    "body": [
                        {
                            "type": "text",
                            "content": "When disease is higher risk, or surveillance criteria are not met, treatment is recommended to achieve cancer control.\n\nMain definitive options typically include: surgery, radiation-based strategies (often with additional components depending on risk).\n\nThe best choice depends on: risk category, age and fitness, anatomy and comorbidities, patient priorities around recovery and side effects."
                        }
                    ]
                }
            ]
        },
        {
            "type": "text",
            "title": "Surgery vs radiation: how the choice is made",
            "content": "Patients often ask: \"Which is better?\"\n\nA better question is: Which is better for my risk profile, life stage, anatomy, and priorities?\n\nFactors considered include: cancer risk category and local extent, urinary symptoms baseline (important), sexual function baseline and priorities, age and overall health, recovery expectations and logistics, availability of experienced teams.\n\nA good clinician will explain trade-offs without bias."
        },
        {
            "type": "composite",
            "title": "Focal therapy and cryoablation: where they fit (selected cases)",
            "items": [
                {
                    "title": "What focal therapy means",
                    "body": [
                        {
                            "type": "text",
                            "content": "Focal therapy is a strategy (treat the lesion), cryoablation is one tool (freezing energy) that may be used within that strategy.\n\nFocal therapy aims to treat a defined area of cancer while sparing the rest of the prostate, in selected cases.\n\nIt is typically discussed when: cancer appears localized to a limited region, risk category and imaging/biopsy features support lesion targeting, patient priorities strongly favour tissue-sparing approaches, there is alignment on follow-up intensity (strict monitoring is essential)."
                        }
                    ]
                },
                {
                    "title": "Important realities",
                    "body": [
                        {
                            "type": "text",
                            "content": "Focal approaches: require careful selection (not everyone is a candidate), require high-quality imaging and targeted biopsy correlation, need close follow-up; sometimes additional treatment is needed later."
                        }
                    ]
                },
                {
                    "title": "Where cryoablation fits",
                    "body": [
                        {
                            "type": "text",
                            "content": "Cryoablation can be used as: a focal therapy tool in selected localized cases, or in other specific contexts depending on clinician judgment.\n\nYour patient should never choose cryo/focal because it \"sounds less invasive.\" They should choose it only if it is oncologically appropriate and if they accept the follow-up discipline required."
                        },
                        {
                            "type": "links",
                            "items": [
                                {
                                    "href": "/specialties/urology/procedures/cryoablation",
                                    "label": "Procedure page: Cryoablation"
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "type": "text",
            "title": "Follow-up after diagnosis and after treatment",
            "content": "A good program supports you through: understanding PSA patterns post-treatment, interpreting follow-up imaging where needed, managing urinary or sexual side effects proactively, psychological stability (decision confidence matters).\n\nFollow-up varies by pathway: surveillance has a strict monitoring protocol, post-treatment has PSA-based monitoring with clear triggers for action."
        },
        {
            "type": "composite",
            "title": "Which page should you go to next?",
            "items": [
                {
                    "title": "If your concern is PSA / MRI / biopsy interpretation",
                    "body": [
                        {
                            "type": "text",
                            "content": "Stay here, then book a consult with your reports"
                        }
                    ]
                },
                {
                    "title": "If your main urinary symptoms are weak stream/nocturia/urgency",
                    "body": [
                        {
                            "type": "links",
                            "items": [
                                {
                                    "href": "/specialties/urology/conditions/bph",
                                    "label": "BPH"
                                },
                                {
                                    "href": "/specialties/urology/conditions/luts-incontinence",
                                    "label": "LUTS and Incontinence"
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "If you want focal options explained carefully",
                    "body": [
                        {
                            "type": "links",
                            "items": [
                                {
                                    "href": "/specialties/urology/procedures/cryoablation",
                                    "label": "Cryoablation"
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "type": "text",
            "title": "Talk to a doctor (quietly, without pressure)",
            "content": "If you're in Mumbai or Pune, you can share: PSA history (values + dates), MRI prostate report (PI-RADS, lesion location), biopsy report (Gleason/Grade Group + cores), any staging scans if done, your priorities (urinary function, sexual function, time off work, anxiety level).\n\nWe will help you: understand your risk category clearly, decide whether surveillance is safe, decide if treatment is recommended, evaluate whether focal therapy discussion is appropriate or not, plan next steps with the right specialist team."
        },
        {
            "type": "cta",
            "items": [
                {
                    "label": "Upload reports for guidance",
                    "action": "upload"
                },
                {
                    "label": "WhatsApp our medical team",
                    "action": "whatsapp"
                },
                {
                    "label": "Book a consult",
                    "action": "book"
                }
            ]
        },
        {
            "type": "faq",
            "title": "FAQs",
            "items": [
                {
                    "q": "Is prostate cancer always aggressive?",
                    "a": "No. Many prostate cancers are slow-growing and can be monitored safely in selected patients. Risk stratification is essential before deciding treatment."
                },
                {
                    "q": "Does a high PSA mean I definitely have cancer?",
                    "a": "No. PSA can rise due to BPH or inflammation. PSA is a signal to evaluate, often with MRI and biopsy when appropriate."
                },
                {
                    "q": "What does Gleason score / Grade Group mean?",
                    "a": "It reflects how the cancer looks under the microscope and correlates with aggressiveness. Higher grade groups typically need definitive treatment planning."
                },
                {
                    "q": "Can I choose active surveillance safely?",
                    "a": "In selected low-risk cases, yes—when done with a structured protocol and clear triggers for treatment."
                },
                {
                    "q": "Is focal therapy \"better\" because it's less invasive?",
                    "a": "Focal therapy can be appropriate in selected cases, but it requires careful selection and strict follow-up. The best choice is the one that matches your risk and provides reliable cancer control."
                },
                {
                    "q": "Where does cryoablation fit?",
                    "a": "Cryoablation is one tool that can be used in selected localized cases (often within a focal strategy). Suitability depends on imaging, biopsy, and risk profile."
                }
            ]
        }
    ]
};

export default prostateCancer;
